Throughout the last three months, 9 analysts have evaluated Guardant Health (NASDAQ:GH), offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of their ...
PALO ALTO, Calif. & MCLEAN, Va.--(BUSINESS WIRE)--Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing artificial intelligence ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Hilary Brueck Every time Hilary publishes a story, you’ll get an alert straight to your inbox!
Wall Street analysts forecast that Guardant Health (GH) will report quarterly loss of $0.55 per share in its upcoming release, pointing to a year-over-year increase of 24.7%. It is anticipated that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results